Eileen Blasi

955 total citations
14 papers, 715 citations indexed

About

Eileen Blasi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Eileen Blasi has authored 14 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Oncology. Recurrent topics in Eileen Blasi's work include Cardiovascular Function and Risk Factors (2 papers), Adipose Tissue and Metabolism (2 papers) and Hormonal Regulation and Hypertension (2 papers). Eileen Blasi is often cited by papers focused on Cardiovascular Function and Risk Factors (2 papers), Adipose Tissue and Metabolism (2 papers) and Hormonal Regulation and Hypertension (2 papers). Eileen Blasi collaborates with scholars based in United States, France and Germany. Eileen Blasi's co-authors include Amy E. Rudolph, Ellen G. McMahon, Eric A.G. Blomme, Ricardo Rocha, Jonathan R. Heyen, Swasti Tiwari, Aileen McHarg, Carolyn Ecelbarger, Ricardo Mourilhe‐Rocha and John F. Van Vleet and has published in prestigious journals such as Cancer Research, Scientific Reports and Kidney International.

In The Last Decade

Eileen Blasi

13 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eileen Blasi United States	10	377	287	215	190	83	14	715
Brasilina Caroccia Italy	21	566 1.5×	262 0.9×	401 1.9×	224 1.2×	92 1.1×	54	1.0k
Mitsuhiro Nishimoto Japan	16	216 0.6×	282 1.0×	95 0.4×	133 0.7×	76 0.9×	28	649
Masayoshi Yoshii Japan	17	192 0.5×	226 0.8×	129 0.6×	337 1.8×	76 0.9×	30	764
Masato Ohsawa Japan	17	205 0.5×	158 0.6×	139 0.6×	396 2.1×	85 1.0×	45	727
Sheng Jiao China	15	180 0.5×	224 0.8×	245 1.1×	99 0.5×	68 0.8×	37	685
Xiaoping Ruan United States	15	282 0.7×	302 1.1×	133 0.6×	252 1.3×	33 0.4×	26	715
Aldo Soro Italy	9	354 0.9×	146 0.5×	200 0.9×	256 1.3×	49 0.6×	14	638
Nozomu Inamoto Japan	18	236 0.6×	372 1.3×	145 0.7×	346 1.8×	57 0.7×	21	851
Motofumi Sasaki Japan	13	334 0.9×	202 0.7×	177 0.8×	139 0.7×	32 0.4×	16	781
Kimberly M. Hoagland United States	13	415 1.1×	227 0.8×	102 0.5×	187 1.0×	28 0.3×	16	735

Countries citing papers authored by Eileen Blasi

Since Specialization

Citations

This map shows the geographic impact of Eileen Blasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Blasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Blasi more than expected).

Fields of papers citing papers by Eileen Blasi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen Blasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Blasi. The network helps show where Eileen Blasi may publish in the future.

Co-authorship network of co-authors of Eileen Blasi

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen Blasi. A scholar is included among the top collaborators of Eileen Blasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen Blasi. Eileen Blasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Karamanlidis, Georgios, Barbora Malecová, Michael A. Cochran, et al.. (2024). Cardiac delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs) for treating genetic cardiomyopathies. Journal of Cardiac Failure. 30. S11–S11.

Barry, Elly, et al.. (2021). Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations. Pediatric Drugs. 23(4). 381–394. 11 indexed citations

Ho, Wei-Hsien, Kathy Delaria, Eileen Blasi, et al.. (2019). Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates. Scientific Reports. 9(1). 2443–2443. 14 indexed citations

Yanochko, Gina M., Allison Vitsky, Jonathan R. Heyen, et al.. (2013). Pan-FGFR Inhibition Leads to Blockade of FGF23 Signaling, Soft Tissue Mineralization, and Cardiovascular Dysfunction. Toxicological Sciences. 135(2). 451–464. 58 indexed citations

Aguirre, Shirley A., et al.. (2010). Cardiovascular Effects in Rats following Exposure to a Receptor Tyrosine Kinase Inhibitor. Toxicologic Pathology. 38(3). 416–428. 17 indexed citations

Blasi, Eileen, et al.. (2009). Effects of Chronic PPAR‐Agonist Treatment on Cardiac Structure and Function, Blood Pressure, and Kidney in Healthy Sprague‐Dawley Rats. PPAR Research. 2009(1). 237865–237865. 27 indexed citations

DePasquale, Michael, Gregory Cadelina, Delvin R. Knight, et al.. (2009). Mechanistic studies of blood pressure in rats treated with a series of cholesteryl ester transfer protein inhibitors. Drug Development Research. 70(1). 35–48. 21 indexed citations

Blasi, Eileen, et al.. (2009). Effects of CP-532,623 and Torcetrapib, Cholesteryl Ester Transfer Protein Inhibitors, on Arterial Blood Pressure. Journal of Cardiovascular Pharmacology. 53(6). 507–516. 12 indexed citations

Tiwari, Swasti, Eileen Blasi, Jonathan R. Heyen, Aileen McHarg, & Carolyn Ecelbarger. (2008). Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats. Pharmacological Research. 57(5). 383–392. 30 indexed citations

10.

Blasi, Eileen, et al.. (2008). Blood pressure and cardiac structure and function evaluation following treatment with sunitinib (SU11248, Sutent®). Journal of Pharmacological and Toxicological Methods. 58(2). 172–172. 1 indexed citations

11.

Marrone, Tami, Dana D. Hu‐Lowe, Maren L. Grazzini, et al.. (2007). PF-00337210, a potent, selective and orally bioavailable small molecule inhibitor of VEGFR-2. Cancer Research. 67. 3992–3992. 7 indexed citations

12.

Blasi, Eileen, et al.. (2007). EFFECTS OF CHRONIC PPAR-AGONIST TREATMENT ON CARDIO-RENAL STRUCTURE, FUNCTION, AND BLOOD PRESSURE IN SPRAGUE–DAWLEY RATS. Journal of Pharmacological and Toxicological Methods. 56(2). e8–e8. 1 indexed citations

13.

Blasi, Eileen, et al.. (2003). Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney International. 63(5). 1791–1800. 431 indexed citations

14.

Heyen, Jonathan R., Eileen Blasi, Kristen J. Nikula, et al.. (2002). Structural, functional, and molecular characterization of the SHHF model of heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 283(5). H1775–H1784. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact